Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-24
DOI
10.1038/s41467-018-05639-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin
- (2018) Zhiguo Li et al. CANCER RESEARCH
- Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity
- (2017) Seraina Faes et al. Oxidative Medicine and Cellular Longevity
- Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot
- (2016) Deborah C.I. Goberdhan et al. Cell Metabolism
- Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
- (2016) Katarzyna Switon et al. IUBMB LIFE
- Sizing up to Divide: Mitotic Cell-Size Control in Fission Yeast
- (2015) Elizabeth Wood et al. Annual Review of Cell and Developmental Biology
- Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy
- (2015) Matthildi Valianou et al. CELL CYCLE
- KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes
- (2015) Lingling Duan et al. CHEMISTRY & BIOLOGY
- mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
- (2015) W. Mo et al. CLINICAL CANCER RESEARCH
- Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis
- (2015) Joanna Trelinska et al. PEDIATRIC BLOOD & CANCER
- Rapamycin-Resistant Poly (ADP-Ribose) Polymerase-1 Overexpression Is a Potential Therapeutic Target in Lymphangioleiomyomatosis
- (2014) Yang Sun et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells
- (2014) Chenggang Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Safety of Sirolimus for Renal Angiomyolipoma in Patients with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis: A Systematic Review
- (2014) Zhu-feng Peng et al. JOURNAL OF UROLOGY
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
- (2014) B. C. Grabiner et al. Cancer Discovery
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
- (2013) Y. Shen et al. CLINICAL CANCER RESEARCH
- Rapamycin Resistance: mTORC1 Substrates Hold Some of the Answers
- (2013) Sang-Oh Yoon et al. CURRENT BIOLOGY
- Reverse-Phase Protein Array Analysis to Identify Biomarker Proteins in Human Pancreatic Cancer
- (2013) Yu-Jing Huang et al. DIGESTIVE DISEASES AND SCIENCES
- Amino acid signalling upstream of mTOR
- (2013) Jenna L. Jewell et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nutrient signaling to mTOR and cell growth
- (2013) Jenna L. Jewell et al. TRENDS IN BIOCHEMICAL SCIENCES
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
- (2010) Bryan T. Hennessy et al. Clinical Proteomics
- Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
- (2009) P. Gulhati et al. CLINICAL CANCER RESEARCH
- Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment
- (2009) K. Inoki et al. HUMAN MOLECULAR GENETICS
- Radiation-induced mitotic catastrophe in PARG-deficient cells
- (2009) J.-C. Ame et al. JOURNAL OF CELL SCIENCE
- Death through a tragedy: mitotic catastrophe
- (2008) H Vakifahmetoglu et al. CELL DEATH AND DIFFERENTIATION
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Possible mechanisms of disease development in tuberous sclerosis
- (2008) Jaroslaw Jozwiak et al. LANCET ONCOLOGY
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation